HCM Hutchison China Meditech ADRs

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:HCM.

$9.74  +0.16 (1.67%)
As of 05/23/2022 12:31:07 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  03/16/2016
Outstanding shares:  172,906,170
Average volume:  664,016
Market cap:   $1,589,007,702
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BYXV9H7

---

Valuation   (See tab for details)

---

PE ratio:   -10.02
PB ratio:   1.66
PS ratio:   5.86
Return on equity:   -16.78%
Net income %:   -60.90%